← Back to Search

Parkinson's disease for Parkinson's Disease (AIDP Trial)

N/A
Waitlist Available
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-18 months
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and the imaging diagnosis will be compared to the movement disorders trained neurologist diagnosis.

Eligible Conditions
  • Parkinson's Disease
  • Multiple System Atrophy
  • Progressive Supranuclear Palsy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Predicted diagnosis accuracy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Progressive Supranuclear PalsyExperimental Treatment1 Intervention
Clinically diagnosed Progressive Supranuclear Palsy
Group II: Parkinson's diseaseExperimental Treatment1 Intervention
Clinically diagnosed Parkinson's disease
Group III: Multiple System Atrophy, Parkinsonian variantExperimental Treatment1 Intervention
Clinically diagnosed Multiple System Atrophy, Parkinsonian variant

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalOTHER
3,001 Previous Clinical Trials
13,308,281 Total Patients Enrolled
Penn State UniversityOTHER
367 Previous Clinical Trials
127,387 Total Patients Enrolled
University of South FloridaOTHER
424 Previous Clinical Trials
189,560 Total Patients Enrolled
~96 spots leftby Mar 2026